Gelesis Holdings Inc (NYSE:GLS) reported FY21 revenue of $11.2M, net loss of $93.3M. GUIDANCE: Gelesis Holdings sees FY2022 revenue of $58 million. For earnings history and...
The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Gelesis...
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Anybody buying in now that GLS is down from $5 something 6/6/22 to $1.80 6/14/22... even with them blowing through operating cash but heavily advertising Plenity?
0
Added $5,10 short squeeze will be epic.. tomorrow🚀🚀🚀🚀🚀🚀